NO147749C - Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive n-acryl-2-hydroxy-1,3-diaminopropaner - Google Patents
Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive n-acryl-2-hydroxy-1,3-diaminopropanerInfo
- Publication number
- NO147749C NO147749C NO781631A NO781631A NO147749C NO 147749 C NO147749 C NO 147749C NO 781631 A NO781631 A NO 781631A NO 781631 A NO781631 A NO 781631A NO 147749 C NO147749 C NO 147749C
- Authority
- NO
- Norway
- Prior art keywords
- diaminopropanes
- acryl
- hydroxy
- preparation
- new therapeutic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19772720968 DE2720968C2 (de) | 1977-05-10 | 1977-05-10 | N↓1↓-Acyl-2-hydroxy-1,3-diaminopropane und Arzneimittel |
| DE2720915A DE2720915C2 (de) | 1977-05-10 | 1977-05-10 | N↓1↓-Acyl-2-hydroxy-1,3-diaminopropane und Arzneimittel mit diesen Verbindungen als Wirkstoff |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO781631L NO781631L (no) | 1978-11-13 |
| NO147749B NO147749B (no) | 1983-02-28 |
| NO147749C true NO147749C (no) | 1983-06-08 |
Family
ID=25771998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO781631A NO147749C (no) | 1977-05-10 | 1978-05-09 | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive n-acryl-2-hydroxy-1,3-diaminopropaner |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US4191770A (no) |
| JP (1) | JPS53141224A (no) |
| AT (1) | AT357144B (no) |
| AU (1) | AU520625B2 (no) |
| CH (1) | CH636845A5 (no) |
| DD (1) | DD135195A5 (no) |
| DK (1) | DK201878A (no) |
| ES (1) | ES469020A1 (no) |
| FR (1) | FR2390422A1 (no) |
| GB (1) | GB1585758A (no) |
| IE (1) | IE46778B1 (no) |
| IL (1) | IL54677A (no) |
| IT (1) | IT1098213B (no) |
| NL (1) | NL7805038A (no) |
| NO (1) | NO147749C (no) |
| NZ (1) | NZ187221A (no) |
| PH (1) | PH14558A (no) |
| SU (1) | SU906365A3 (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2459235A1 (fr) * | 1979-06-14 | 1981-01-09 | Sanofi Sa | Nouveaux derives de sulfonyl-aniline, leur procede de preparation et leur application therapeutique |
| JPS58177953A (ja) * | 1982-04-13 | 1983-10-18 | Eisai Co Ltd | ポリプレニルカルボン酸アミドおよびその製造方法 |
| US4596813A (en) * | 1982-11-04 | 1986-06-24 | Chevron Research Company | Pyridylcarbonyl and thiocarbonyl derivatives useful as fungicides |
| WO1994015906A1 (en) * | 1993-01-15 | 1994-07-21 | Agouron Pharmaceuticals, Inc. | Hiv protease inhibitors and their preparation |
| US5824821A (en) * | 1997-02-07 | 1998-10-20 | Nycomed Imaging As | Process for the preparation of iodinated contrast agents and intermediates therefor |
| KR100619639B1 (ko) * | 1997-11-07 | 2006-09-06 | 파마시아 앤드 업존 캄파니 엘엘씨 | 옥사졸리디논의 제조 방법 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1805355A (en) * | 1929-01-02 | 1931-05-12 | Ig Farbenindustrie Ag | Basic compounds and process of preparing them |
| US2658076A (en) * | 1951-06-12 | 1953-11-03 | Searle & Co | N-dialkylaminoalkyl derivatives of alpha, beta-diarylalkanoamides and their salts |
| BE794424A (fr) * | 1972-01-24 | 1973-07-23 | Science Union & Cie | Nouveaux dibenzocycloheptenes, leur procede d'obtention et leur application comme medicament |
| DE2221558C2 (de) * | 1972-05-03 | 1982-12-02 | Kali-Chemie Ag, 3000 Hannover | 5-Phenyl-2,3-dihydro-1H-1,4-benzodiazepine und ihre Säureadditionssalze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| GB1374366A (en) * | 1972-07-21 | 1974-11-20 | Science Union & Cie | Propanol derivatives and a process for their preparation |
| GB1436593A (en) * | 1973-03-15 | 1976-05-19 | Science Union & Cie | N-substituted acetamides processes for their preparation and pharmaceutical compositions containing them apparatus for processing photograp |
| DE2314993A1 (de) * | 1973-03-26 | 1974-10-03 | Kali Chemie Pharma Gmbh | Neue benzodiazepinderivate und verfahren zu deren herstellung |
| US4141987A (en) * | 1974-06-05 | 1979-02-27 | Imperial Chemical Industries Limited | 1-Aryloxy-3-thenamidoalkylamino-2-propanol derivatives |
| DE2448259A1 (de) * | 1974-10-10 | 1976-04-22 | Kali Chemie Pharma Gmbh | Verfahren zur herstellung von 2-halogenmethyl-1,4-benzodiazepinen |
| US4144343A (en) * | 1978-01-04 | 1979-03-13 | Merck & Co., Inc. | Heterocycle substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines |
-
1978
- 1978-04-21 ES ES469020A patent/ES469020A1/es not_active Expired
- 1978-04-28 US US05/900,998 patent/US4191770A/en not_active Expired - Lifetime
- 1978-05-08 IE IE921/78A patent/IE46778B1/en unknown
- 1978-05-08 DD DD78205251A patent/DD135195A5/xx unknown
- 1978-05-08 GB GB18322/78A patent/GB1585758A/en not_active Expired
- 1978-05-09 DK DK201878A patent/DK201878A/da not_active Application Discontinuation
- 1978-05-09 IL IL54677A patent/IL54677A/xx unknown
- 1978-05-09 FR FR7813736A patent/FR2390422A1/fr active Granted
- 1978-05-09 AT AT335178A patent/AT357144B/de not_active IP Right Cessation
- 1978-05-09 AU AU35941/78A patent/AU520625B2/en not_active Expired
- 1978-05-09 NO NO781631A patent/NO147749C/no unknown
- 1978-05-09 IT IT7823159A patent/IT1098213B/it active
- 1978-05-09 JP JP5488278A patent/JPS53141224A/ja active Granted
- 1978-05-09 CH CH503478A patent/CH636845A5/de not_active IP Right Cessation
- 1978-05-10 SU SU782616144A patent/SU906365A3/ru active
- 1978-05-10 NZ NZ187221A patent/NZ187221A/xx unknown
- 1978-05-10 NL NL7805038A patent/NL7805038A/xx not_active Application Discontinuation
- 1978-05-10 PH PH21128A patent/PH14558A/en unknown
-
1981
- 1981-03-16 US US06/243,746 patent/US4402981A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IL54677A0 (en) | 1978-07-31 |
| IL54677A (en) | 1981-02-27 |
| PH14558A (en) | 1981-09-24 |
| IE780921L (en) | 1978-11-10 |
| ES469020A1 (es) | 1979-09-01 |
| AT357144B (de) | 1980-06-25 |
| CH636845A5 (de) | 1983-06-30 |
| AU3594178A (en) | 1979-11-15 |
| ATA335178A (de) | 1979-11-15 |
| DD135195A5 (de) | 1979-04-18 |
| US4402981A (en) | 1983-09-06 |
| DK201878A (da) | 1979-02-14 |
| NZ187221A (en) | 1980-12-19 |
| JPS6252740B2 (no) | 1987-11-06 |
| SU906365A3 (ru) | 1982-02-15 |
| AU520625B2 (en) | 1982-02-11 |
| GB1585758A (en) | 1981-03-11 |
| NL7805038A (nl) | 1978-11-14 |
| FR2390422A1 (fr) | 1978-12-08 |
| IT1098213B (it) | 1985-09-07 |
| NO147749B (no) | 1983-02-28 |
| US4191770A (en) | 1980-03-04 |
| NO781631L (no) | 1978-11-13 |
| IE46778B1 (en) | 1983-09-21 |
| JPS53141224A (en) | 1978-12-08 |
| IT7823159A0 (it) | 1978-05-09 |
| FR2390422B1 (no) | 1980-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO147148C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive fenyletanolaminderivater | |
| NO149962C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater | |
| NO151085C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive peptidylargininaldehydderivater | |
| NO151461C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolidinderivater | |
| NO146392C (no) | Analogifremgangsmaate ved fremstilling av nye analgesisk aktive n-acetyl-para-aminofenyl-n`-acetyl-aminoalkansyreester-derivater | |
| NO154426C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive trans-3-(4-okso-4h-kinazolin-3-yl)-2-propensyrederivater. | |
| NO148642C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye prostacyclinderivater | |
| NO145791C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive imidazolderivater | |
| NO152654C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive derivater av 7-acylamido-3-cephem-4-karboksylsyre | |
| NO148926C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive, nye merkaptoimidazolderivater | |
| NO145198C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3 | |
| NO152414C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2,6-dialkoksybenzamider | |
| NO149313C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner | |
| NO149037C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner | |
| NO154920C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye pyridothienotriaziner. | |
| NO148070C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive angiotensin ii analoger | |
| NO144457C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner | |
| NO150041C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive lactamforbindelser | |
| NO150158C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater | |
| NO147749C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive n-acryl-2-hydroxy-1,3-diaminopropaner | |
| NO154396C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive halovincamonderivater. | |
| NO154795C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1,2,4-oxadiazolin-5-on-derivater. | |
| NO149964C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-(tetrazol-5-yl)-1-azaxanthoner | |
| NO154088C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive tetrahydrokinoliner. | |
| NO152556C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive antracen-biskarbonylhydrazoner |